(HealthDay)—For persons with a history of previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the neutralizing antibody titer is higher after one dose of mRNA vaccine than after two vaccine doses among previously uninfected persons, according to a research letter published online April 14 in the New England Journal of Medicine.
Gabriele Anichini, from the University of Siena in Italy, and colleagues conducted an observational cohort study involving 100 health care workers, including 38 who had a documented history of SAR-CoV-2 infection and 62 who had not been previously infected. Both groups received the mRNA vaccine BNT162b2. Serum samples were obtained 10 days after administration of the first dose in previously infected participants and 10 days after the second dose in previously uninfected participants.
The researchers observed no significant difference in circulating anti-spike immunoglobulin G antibody titers between the samples from previously infected and uninfected participants (mean level: 20,120 and 22,639 arbitrary units/mL, respectively). Samples from previously infected participants had significantly higher levels of neutralizing antibodies than those from previously uninfected participants (geometric mean titer: 569 versus 118).
“These findings provide evidence that after the administration of a single dose of vaccine, the humoral response against SARS-CoV-2 in persons with a history of SARS-CoV-2 infection is greater than the response in previously uninfected participants who have received a second dose,” the authors write.
COVID-19 survivors might need just one dose of two-part vaccine
Copyright © 2021 HealthDay. All rights reserved.
Response to one COVID-19 vaccine dose strong in previously infected (2021, April 16)
retrieved 17 April 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- Life expectancy in India dropped by two years due to COVID-19: Study - October 23, 2021
- US’ work with India on vaccine manufacturing saving people’s lives, says DFC chief - October 23, 2021
- Bengal reports steady Covid surge for third consecutive day - October 23, 2021
- Sri Lanka gives booster shots to front-line workers - October 23, 2021
- 3 children die of dengue in Uttar Pradesh - October 23, 2021
- India is close to turning the pandemic tide: Poonawalla - October 21, 2021
- Covishield may offer over 90% protection against death from Delta variant: Study - October 21, 2021
- PM Modi congratulated health workers on vaccinating 100 crore India’s population - October 21, 2021
- South African regulator rejects Russia’s COVID-19 vaccine - October 20, 2021
- Second wave of pandemic not receded yet, third wave feared post-Diwali: Maha health minister - October 20, 2021